Status:

RECRUITING

Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy

Lead Sponsor:

Hecheng Li M.D., Ph.D

Collaborating Sponsors:

Shanghai Chest Hospital

Shanghai Zhongshan Hospital

Conditions:

Esophageal Neoplasms

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

This randomized controlled trial will evaluate the effects of preoperative enteral immunonutrition in esophageal cancer patients undergoing neoadjuvant therapy. The purpose of this study is to determi...

Detailed Description

Esophageal cancer ranks the fourth in mortality and the sixth in incidence among cancers in China according to the latest report of cancer epidemiology. Although the development of neoadjuvant therapy...

Eligibility Criteria

Inclusion

  • Histologically confirmed esophageal cancer
  • Staging as cT2N0M0 with high-risk lesions (lymphovascular invasion, ≥3cm, poorly differentiated) / cT1b-2N+M0 / cT3-4aN0-3M0 with the need of neoadjuvant therapy before radical esophagectomy
  • Tolerance with oral intake (at least fluid diet)
  • Eastern Cooperative Oncology Group (ECOG) performance status ≤2
  • Body Mass Index (BMI) ≥ 18.5 kg/m2 before recruitment
  • Patient's approval and written informed consent

Exclusion

  • Expected survival time less than 6 months
  • Complete dysphagia
  • Pregnant or breast-feeding women
  • Unable to obey the interventions because of any reasons
  • Serious co-morbidities (cardiac, pulmonary, liver, kidney, brain, hematologic, endocrine and other diseases) in patients who cannot tolerate neoadjuvant therapy and/or surgery
  • History of previous thoracic or abdominal surgery
  • History of other malignant tumor (previous or current)
  • Patients with primary small cell carcinoma of the esophagus

Key Trial Info

Start Date :

November 10 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2028

Estimated Enrollment :

244 Patients enrolled

Trial Details

Trial ID

NCT04513418

Start Date

November 10 2020

End Date

December 31 2028

Last Update

May 14 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China, 200011

2

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China, 200025

3

Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University

Shanghai, Shanghai Municipality, China, 200030

4

Zhongshan Hospital Affiliated to Fudan University

Shanghai, Shanghai Municipality, China, 200032